Your search returned 23 results.

Results
	21.	Towards optimal personalized diet and vitamin supplementation in NET patients. [electronic resource] by de Hosson, L D Stelwagen, J Bouma, G Sijtema, B Huitema, S van Faassen, H J R de Bock, G H de Groot, D J A Campmans-Kuijpers, M J E Kema, I P de Vries, E G E Walenkamp, A M E Producer: 20190301 In: Endocrine-related cancer vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial. [electronic resource] by Beije, N Kraan, J Taal, W van der Holt, B Oosterkamp, H M Walenkamp, A M Beerepoot, L Hanse, M van Linde, M E Otten, A Vernhout, R M de Vos, F Y F Gratama, J W Sleijfer, S van den Bent, M J Producer: 20150930 In: British journal of cancer vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureus. [electronic resource] by Boer, J C Domanska, U M Timmer-Bosscha, H Boer, I G J de Haas, C J C Joseph, J V Kruyt, F A E de Vries, E G E den Dunnen, W F A van Strijp, J A G Walenkamp, A M E Producer: 20130423 In: British journal of cancer vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)